# MAP3K6

## Overview
MAP3K6, or mitogen-activated protein kinase kinase kinase 6, is a gene that encodes a serine/threonine kinase involved in critical cellular signaling pathways, particularly the c-Jun N-terminal Kinase (JNK) and p38 signaling cascades. These pathways are integral to cellular stress responses, apoptosis, and inflammation regulation. The MAP3K6 protein is predominantly expressed in tissues such as the skin, gastrointestinal tract, and lungs, where it plays a vital role in maintaining cellular homeostasis and responding to oxidative stress (Gaston2014Germline). As a kinase, MAP3K6 forms a heteromeric complex with its paralog MAP3K5, which is essential for its stability and activation. This interaction underscores its potential role as a tumor suppressor, particularly in the context of gastric cancer, where its expression is often reduced (Gaston2014Germline). Additionally, MAP3K6 is implicated in various diseases, including familial gastric cancer and cerebral small vessel disease, highlighting its significance in both normal physiology and disease pathogenesis (Weren2018Role; Nguyen2022MAP3K).

## Function
MAP3K6, also known as mitogen-activated protein kinase kinase kinase 6, is a serine/threonine kinase involved in the c-Jun N-terminal Kinase (JNK) and p38 signaling cascades, which are crucial for cellular stress responses. It is predominantly expressed in the skin, gastrointestinal tract, and lungs (Gaston2014Germline). In healthy cells, MAP3K6 plays a significant role in regulating apoptosis and inflammation, which are essential for maintaining cellular homeostasis and responding to stress (Gaston2014Germline). 

MAP3K6 forms a heteromeric complex with its paralog MAP3K5, which prevents its degradation and promotes its autophosphorylation and activation. This activation is particularly important in the presence of oxidative stress and reactive oxygen species (ROS), where active phospho-MAP3K6 triggers the JNK and p38 cascades, leading to apoptosis (Gaston2014Germline). The balance between MAP3K6 and MAP3K5 is critical for their respective roles in promoting apoptosis and tumor suppression versus pro-inflammatory and anti-apoptotic functions (Gaston2014Germline). 

MAP3K6's involvement in these pathways underscores its importance in normal cellular function and its potential role as a tumor suppressor, particularly in the gastrointestinal tract, where its expression is notably reduced in gastric cancer tumors compared to healthy tissue (Gaston2014Germline).

## Clinical Significance
Mutations in the MAP3K6 gene have been associated with familial gastric cancer. Studies have identified germline mutations in MAP3K6 in families with a history of gastric cancer, suggesting a potential role in genetic predisposition to the disease. These mutations may act as tumor suppressors, with evidence indicating that MAP3K6 expression is reduced in gastric cancer tumors (Gaston2014Germline). However, the clinical significance of MAP3K6 mutations in gastric cancer susceptibility is debated. Some research suggests that deleterious variants in MAP3K6 occur frequently in the general population, indicating that MAP3K6 should not be considered a gastric cancer predisposition gene (Weren2018Role).

MAP3K6 is also implicated in other conditions. It is associated with cerebral small vessel disease, which can lead to stroke, cognitive impairment, and tremor (Nguyen2022MAP3K). In cancer, MAP3K6 expression levels have been linked to patient survival outcomes in various cancer types, with positive associations in some cancers like breast and stomach adenocarcinomas, and negative associations in others such as liver hepatocellular carcinoma (Nguyen2022MAP3K). These findings suggest that MAP3K6 may play diverse roles in disease pathogenesis depending on the context.

## Interactions
MAP3K6, also known as mitogen-activated protein kinase kinase kinase 6, is involved in several protein interactions that are crucial for its function in cellular signaling pathways. It is a part of the c-Jun N-terminal Kinase (JNK) and p38 signaling cascades and is known to form a heteromeric complex with its paralog MAP3K5. This interaction is essential for preventing the degradation of MAP3K6 and promoting its activation. The balance between the pro-apoptotic and tumor-suppressing roles of MAP3K6 and the pro-inflammatory/anti-apoptotic roles of MAP3K5 is maintained through this interaction (Gaston2014Germline).

MAP3K6 is also involved in the Ras-MAPK signaling pathway, as identified in studies on colorectal cancer. It is part of a network of genes that interact with key signaling pathways, including Wnt and Ras-MAPK, highlighting its role in complex regulatory networks (Jacobsen2018Aurora). The interaction between MAP3K6 and other proteins in these pathways suggests its involvement in regulating cellular responses such as apoptosis and inflammation, which are critical in cancer pathogenesis (Gaston2014Germline). However, specific details on transient interactions or nucleic acid interactions are not provided in the available context.


## References


[1. (Jacobsen2018Aurora) Annika Jacobsen, Linda J. W. Bosch, Sanne R. Martens-de Kemp, Beatriz Carvalho, Anke H. Sillars-Hardebol, Richard J. Dobson, Emanuele de Rinaldis, Gerrit A. Meijer, Sanne Abeln, Jaap Heringa, Remond J. A. Fijneman, and K. Anton Feenstra. Aurora kinase a (aurka) interaction with wnt and ras-mapk signalling pathways in colorectal cancer. Scientific Reports, May 2018. URL: http://dx.doi.org/10.1038/s41598-018-24982-z, doi:10.1038/s41598-018-24982-z. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-018-24982-z)

[2. (Weren2018Role) Robbert D A Weren, Rachel S van der Post, Ingrid P Vogelaar, J Han van Krieken, Liesbeth Spruijt, Jan Lubinski, Anna Jakubowska, Urszula Teodorczyk, Cora M Aalfs, Liselotte P van Hest, Carla Oliveira, Eveline J Kamping, Hans K Schackert, Guglielmina N Ranzani, Encarna B Gómez García, Frederik J Hes, Elke Holinski-Feder, Maurizio Genuardi, Margreet G E M Ausems, Rolf H Sijmons, Anja Wagner, Lizet E van der Kolk, Annemieke Cats, Inga Bjørnevoll, Nicoline Hoogerbrugge, and Marjolijn J L Ligtenberg. Role of germline aberrations affecting ctnna1, map3k6 and myd88 in gastric cancer susceptibility. Journal of Medical Genetics, 55(10):669–674, January 2018. URL: http://dx.doi.org/10.1136/jmedgenet-2017-104962, doi:10.1136/jmedgenet-2017-104962. This article has 34 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2017-104962)

[3. (Gaston2014Germline) Daniel Gaston, Samantha Hansford, Carla Oliveira, Mathew Nightingale, Hugo Pinheiro, Christine Macgillivray, Pardeep Kaurah, Andrea L. Rideout, Patricia Steele, Gabriela Soares, Weei-Yuarn Huang, Scott Whitehouse, Sarah Blowers, Marissa A. LeBlanc, Haiyan Jiang, Wenda Greer, Mark E. Samuels, Andrew Orr, Conrad V. Fernandez, Jacek Majewski, Mark Ludman, Sarah Dyack, Lynette S. Penney, Christopher R. McMaster, David Huntsman, and Karen Bedard. Germline mutations in map3k6 are associated with familial gastric cancer. PLoS Genetics, 10(10):e1004669, October 2014. URL: http://dx.doi.org/10.1371/journal.pgen.1004669, doi:10.1371/journal.pgen.1004669. This article has 52 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1004669)

[4. (Nguyen2022MAP3K) Khoa Nguyen, Minh N. Tran, Andrew Rivera, Thomas Cheng, Gabrielle O. Windsor, Abraham B. Chabot, Jane E. Cavanaugh, Bridgette M. Collins-Burow, Sean B. Lee, David H. Drewry, Patrick T. Flaherty, and Matthew E. Burow. Map3k family review and correlations with patient survival outcomes in various cancer types. Frontiers in Bioscience-Landmark, 27(5):167, May 2022. URL: http://dx.doi.org/10.31083/j.fbl2705167, doi:10.31083/j.fbl2705167. This article has 11 citations.](https://doi.org/10.31083/j.fbl2705167)